Female Lower Urinary Tract Symptom Prevention and Treatment Strategies on Social Media: Mixed Correlation With Evidence.
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
01
03
2020
revised:
21
05
2020
accepted:
28
06
2020
pubmed:
17
7
2020
medline:
5
2
2022
entrez:
17
7
2020
Statut:
ppublish
Résumé
To evaluate the level of evidence behind recommendations on social media for disease prevention in five lower urinary tract symptoms. We conducted a digital analysis of anonymous online posts on social media sites collected by a social media data mining service. One thousand posts about pelvic organ prolapse, stress urinary incontinence, overactive bladder, urinary tract infection, and interstitial cystitis/bladder pain syndrome were randomly selected. We analyzed these posts for recommendations regarding the prevention and treatment of these diseases, which were then compared to recommendations in available clinical guidelines and assessed for level of evidence. A total of 158 of 1000 posts contained 239 prevention strategies. For pelvic organ prolapse, there were 41 strategies identified, 25 (61%) of which had no evidence. For urinary tract infection 14 of 58 (29%) had no evidence, including recommendations for dietary modifications and urinary alkalization. For overactive bladder 8 of 28 (29%) had level 4 or no evidence. For stress urinary incontinence, 12 of 34 (36%) of prevention strategies had no evidence, such as laser rejuvenation and bladder training. Interstitial cystitis had the highest number of prevention strategies, and most were low or nonevidence based (70/79, 89%). Prevention and treatment strategies are common in online discussions of pelvic floor disorders, but at least one third of these recommendations have no evidential support. There is a role for further online education and social media engagement by health care specialists to promote evidence-based practices.
Identifiants
pubmed: 32673678
pii: S0090-4295(20)30821-9
doi: 10.1016/j.urology.2020.06.056
pmc: PMC9354551
mid: NIHMS1793353
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
139-145Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK106786
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
JAMA Intern Med. 2018 Nov 1;178(11):1509-1515
pubmed: 30285042
Br J Obstet Gynaecol. 1997 May;104(5):579-85
pubmed: 9166201
J Urol. 2020 May;203(5):962-968
pubmed: 31855097
BJOG. 2000 Dec;107(12):1460-70
pubmed: 11192101
Urology. 2011 Oct;78(4):764-7
pubmed: 21862115
Obstet Gynecol. 2014 Jan;123(1):141-148
pubmed: 24463674
Urol Ann. 2014 Apr;6(2):122-6
pubmed: 24833822
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005131
pubmed: 18425910
J Med Internet Res. 2016 Nov 7;18(11):e286
pubmed: 27821383
PLoS One. 2015 Sep 18;10(9):e0136265
pubmed: 26383760
Int Urogynecol J. 2015 Jun;26(6):795-804
pubmed: 25410372
J Urol. 2015 May;193(5):1572-80
pubmed: 25623739
Neurourol Urodyn. 2017 Apr;36(4):876-881
pubmed: 28444711
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003882
pubmed: 22161382
Gynecol Endocrinol. 2015 Oct;31(10):828-32
pubmed: 26291799
Am J Obstet Gynecol. 2016 Nov;215(5):654.e1-654.e10
pubmed: 27319368
J Urol. 2019 Aug;202(2):282-289
pubmed: 31042112
BJU Int. 2003 Jul;92(1):69-77
pubmed: 12823386
J Urol. 2009 Jan;181(1):193-7
pubmed: 19013621
Int Urogynecol J. 2020 Feb;31(2):243-248
pubmed: 31832718
Int Urogynecol J. 2015 Apr;26(4):551-5
pubmed: 25344222
Am J Obstet Gynecol. 2016 Jul;215(1):34-57
pubmed: 26851599
J Urol. 2018 Dec;200(6):1174-1191
pubmed: 29940246
Neurourol Urodyn. 2016 Jan;35(1):15-20
pubmed: 25400065
BJU Int. 2006 Apr;97(4):752-7
pubmed: 16536767